💊 Fármacos A-Z 🧬 Dianas 🛠 Herramientas 📚 Guías
Todos los fármacos Clases de fármacos Áreas terapéuticas Efectos Secundarios
Guías Glosario Línea de tiempo
Comparaciones Recorridos de fármacos Familias farmacológicas
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

.Alpha.1-Proteinase Inhibitor Human

CHEMBL4297879 Phase 4 Aprobado Protein
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
— g/mol
LogP
—
Phase
4

A purified protein extracted from pooled human plasma used to augment deficient levels of alpha-1 antitrypsin in people with hereditary alpha-1 antitrypsin deficiency, a genetic condition that leads to progressive lung destruction resembling emphysema. Regular infusions help protect the lungs from neutrophil elastase, an enzyme that would otherwise break down lung tissue.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

A purified protein extracted from pooled human plasma used to augment deficient levels of alpha-1 antitrypsin in people with hereditary alpha-1 antitrypsin deficiency, a genetic condition that leads to progressive lung destruction resembling emphysema. Regular infusions help protect the lungs from neutrophil elastase, an enzyme that would otherwise break down lung tissue.

Yes, .Alpha.1-Proteinase Inhibitor Human is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4297879. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.